Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Amendment 712 to House Bill 3
116th Congress(2019-2020)
An amendment numbered 2 printed in Part B of House Report 116-334 to require CMS to create and implement a measure in the Star Ratings program evaluating Medicare Advantage and Part D plans on how well they provide access to biosimilar drugs.
Agreed To
Agreed to in House on Dec 12, 2019
Sponsor
Democrat
Submitted
Dec 12, 2019
Latest Action
Dec 12, 2019
Origin Chamber
House
Type
Amendment
Amendment
A proposed change to a pending text (e.g., a bill, resolution, another amendment, or a treaty [or an associated resolution of ratification]).
Amendment Number
712
Congress
116
Sponsorship by Party
Democrat
Paul Tonko
New York
Actions (4)
12/12/2019
House amendment agreed to: On agreeing to the Tonko amendment (A002) Agreed to by voice vote.
12/12/2019
On agreeing to the Tonko amendment (A002) Agreed to by voice vote.
12/12/2019
Amendment (A002) offered by Mr. Tonko. (consideration: CR H10202-10204; text: CR H10202-10203)
12/12/2019
House amendment offered
Amended Bill
Dec 12, 2019
Passed House
107
Sponsorship
House Bill 3
Elijah E. Cummings Lower Drug Costs Now Act
Active
Amendments
Public Record
Record Updated
Feb 8, 2022 11:01:28 PM